Details of the Drug Combinations

General Information of This Drug (ID: DM8X2EH)

Drug Name
Everolimus   DM8X2EH
Synonyms
Afinitor; Afinitor (TN); CERTICAN(R); Certican; Certican (TN); Everolimus (JAN/USAN/INN); Everolimus [USAN]; MTOR kinase inhibitors; NVP-RAD-001; RAD 001; RAD-001; RAD-001C; RAD001; RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus; SDZ-RAD; Zortress
Indication
Disease Entry ICD 11 Status REF
Advanced cancer 2A00-2F9Z Approved [1]
Advanced/metastatic breast cancer 2C60 Approved [2]
Brainstem neoplasm N.A. Approved [1]
Breast carcinoma N.A. Approved [1]
Graft-versus-host disease 4B24 Approved [1]
Intracranial meningioma N.A. Approved [1]
Leukemia N.A. Approved [1]
Lung cancer 2C25.0 Approved [1]
Mucosal melanoma N.A. Approved [1]
Multiple sclerosis 8A40 Approved [1]
Plasma cell myeloma 2A83.1 Approved [1]
Prostate cancer 2C82.0 Approved [1]
Renal cell carcinoma 2C90 Approved [3]
Salivary gland squamous cell carcinoma N.A. Approved [1]
Tuberous sclerosis LD2D.2 Approved [1]
Kidney cancer 2C90.0 Phase 3 [3]
Castration-resistant prostate carcinoma N.A. Investigative [1]
Colon cancer 2B90.Z Investigative [1]
Middle East Respiratory Syndrome (MERS) 1D64 Investigative [4]
Neuroblastoma 2D11.2 Investigative [1]
Pancreatic acinar cell carcinoma N.A. Investigative [1]
Polycystic kidney disease GB8Y Investigative [1]
Severe acute respiratory syndrome (SARS) 1D65 Investigative [4]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

200 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
(-)-englerin A + Everolimus DCLG9G5 (-)-englerin A Ewing sarcoma (Cell Line: TC-71) [5]
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole + Everolimus DCO1WDG 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
ABT-263 + Everolimus DCV6NCG ABT-263 Ewing sarcoma (Cell Line: TC-71) [6]
Acarbose + Everolimus DCWN9E5 Acarbose Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Acetazolamide + Everolimus DC168S3 Acetazolamide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Amiloride + Everolimus DCAWTUW Amiloride Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Anamorelin + Everolimus DCVSWVO Anamorelin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Aprepitant + Everolimus DC4MCYT Aprepitant Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Asenapine + Everolimus DC3ZV8K Asenapine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
AZD8055 + Everolimus DC3X8J9 AZD8055 Ewing sarcoma (Cell Line: TC-71) [5]
Benserazide + Everolimus DCGYKHP Benserazide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
BIO-300 + Everolimus DC3O7AR BIO-300 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Brincidofovir + Everolimus DCAU1RP Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
BRL-15572 + Everolimus DCZ5PV4 BRL-15572 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Buspirone + Everolimus DCTVNME Buspirone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Cantharidin + Everolimus DCGYZK0 Cantharidin Ewing sarcoma (Cell Line: TC-71) [5]
Carglumic acid + Everolimus DCA9FYF Carglumic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Chlormezanone + Everolimus DCTI0A9 Chlormezanone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Chloroquine + Everolimus DCLRK6W Chloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
CHS-828 + Everolimus DCCVZXX CHS-828 Ewing sarcoma (Cell Line: TC-71) [5]
Cinacalcet + Everolimus DCCADZW Cinacalcet Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Cytarabine + Everolimus DCEN09I Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Decitabine + Everolimus DCRKAJ2 Decitabine Ewing sarcoma (Cell Line: TC-71) [5]
Diazoxide + Everolimus DCON1GU Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dichlorphenamide + Everolimus DCF7RYZ Dichlorphenamide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dopamine + Everolimus DCBBMX3 Dopamine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Emetine + Everolimus DCN5ALW Emetine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Entacapone + Everolimus DCYTGB8 Entacapone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Epothilone D + Everolimus DCQ6GPB Epothilone D Ewing sarcoma (Cell Line: TC-71) [5]
Evacetrapib + Everolimus DCPNUMK Evacetrapib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + Ribavirin-TP DCQRL6P Ribavirin-TP Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Sertraline DCO2I3F Sertraline Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Mebutamate DC3W6KF Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Bepridil DCGSKCQ Bepridil Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Gefitinib DC3X54T Gefitinib Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Ruxolitinib DCBF92V Ruxolitinib T-cell leukemia/lymphoma (Cell Line: ED-40515) [5]
Everolimus + Ombrabulin DCZUQ6M Ombrabulin Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Kanamycin DCOFGNB Kanamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Triamterene DCOR8JC Triamterene Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Trametinib DCBBMNI Trametinib Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + Trametinib DCUZG52 Trametinib Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + Trametinib DC5EVSE Trametinib Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + Dactinomycin DCW2IPM Dactinomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Epinephrine DC0RHLU Epinephrine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + MK-1775 DC40VKH MK-1775 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + JQ1 DC9SOGG JQ1 Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + JQ1 DC6SJF4 JQ1 Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + JQ1 DC5D4JM JQ1 Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + JQ1 DC7O1KK JQ1 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Carfilzomib DCNNAMF Carfilzomib Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Artemether DCT44MN Artemether Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + PMID28460551-Compound-2 DCJ4HAU PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Crizotinib DCJE23G Crizotinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + Panobinostat DCEQGGL Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + Vinblastine DCH36Z1 Vinblastine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Ixazomib DC10QA6 Ixazomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + Belinostat DCKIJUY Belinostat Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + Belinostat DCXZCZL Belinostat Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + Belinostat DCGOM2F Belinostat Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + Fomepizole DC9004N Fomepizole Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Fomepizole DCAR6JY Fomepizole Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Eltanexor oral DCWQAKD Eltanexor oral Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Acalabrutinib DCODIQS Acalabrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [5]
Everolimus + AZD8055 DC249EH AZD8055 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Formononetin DCKUQD2 Formononetin Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Acitretin DCNBZ6F Acitretin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + GDC-0084 DCIRVQU GDC-0084 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + PMID25656651-Compound-5 DCBTVJN PMID25656651-Compound-5 Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + Ceritinib DCDYWSN Ceritinib Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + Ceritinib DCFVD8M Ceritinib Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + Ceritinib DC3T6MH Ceritinib Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + BHV-0223 DCDOCX1 BHV-0223 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Metyrosine DCYJR4M Metyrosine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Exherin DCQWHFD Exherin Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Testosterone cypionate DCQ4A4L Testosterone cypionate Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + AT7519 DCNV1VG AT7519 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Amodiaquine DCS4SO7 Amodiaquine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Triptolide DCL1KKW Triptolide Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + Itraconazole DCS6I8C Itraconazole Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Daporinad DCMEETU Daporinad Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + LY2523355 DCR41TG LY2523355 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + K-134 DCFDVK9 K-134 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Memantine DCWKD22 Memantine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Docetaxel DCSOV8Z Docetaxel Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + THAPSIGARGIN DCSOD22 THAPSIGARGIN Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Phenprocoumon DCF1C6Z Phenprocoumon Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Marizomib DCQXCKA Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + JZL195 DCW7FB1 JZL195 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + AEE-788 DCBDWNM AEE-788 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Cotellic DCLBUJD Cotellic Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + Cotellic DC436QT Cotellic Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + Cotellic DC14076 Cotellic Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + Phensuximide DCZAKKG Phensuximide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Cycloheximide DCB9Y5R Cycloheximide Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + PHA-739358 DC0UU84 PHA-739358 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Mitomycin DCVEFHK Mitomycin Diffuse large B cell lymphoma (Cell Line: TMD8) [5]
Everolimus + Mitomycin DCI2GB9 Mitomycin Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Clopidogrel DCL6PVW Clopidogrel Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Vincristine DCFH9CN Vincristine Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Bosentan DCQNFAA Bosentan Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Pelitinib DCM5YIY Pelitinib Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Triflupromazine DCIKMF2 Triflupromazine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Niclosamide DCU4PVD Niclosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Trazodone DCHL69Q Trazodone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + GSK2126458 DC9DUE4 GSK2126458 Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + GSK2126458 DCXQL0V GSK2126458 Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + Darunavir DCJAU9K Darunavir Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + ABT-263 DCL2MHQ ABT-263 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + BGJ398 DCFH9OK BGJ398 Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + Mebendazole DCT8IGE Mebendazole Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + Bardoxolone methyl DCHHXPX Bardoxolone methyl Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Ispinesib DCMAHMS Ispinesib Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Clascoterone DC92EHU Clascoterone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + TG100801 DCDAYUI TG100801 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + BMS-754807 DCL0II0 BMS-754807 Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + BMS-754807 DC3IED4 BMS-754807 Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + BMS-754807 DCTADUS BMS-754807 Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + Trimethobenzamide DCN3KWY Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Eptifibatide DC4VUZL Eptifibatide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Ethambutol DCWVGZ1 Ethambutol Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Quinine DC3J6O1 Quinine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + MK-2206 DCLNVPB MK-2206 Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + MK-2206 DC8FVGN MK-2206 Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + Pomalidomide DCXE6A9 Pomalidomide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + NVP-AUY922 DC0CH6X NVP-AUY922 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + THZ1 DC7M0WS THZ1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Everolimus + Mitotane DCBX0UW Mitotane Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Hydralazine DCHKUDN Hydralazine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Mefloquine DCZVM37 Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Fosfomycin DCFDJQF Fosfomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Doxorubicin DC36WVF Doxorubicin Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Iloprost DC512Z5 Iloprost Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + SCH772984 DCHKL54 SCH772984 Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
Everolimus + SCH772984 DC723LF SCH772984 Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
Everolimus + SCH772984 DCIFOET SCH772984 Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
Everolimus + Albendazole DCBHBXV Albendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Ibrutinib DCB8YYZ Ibrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [5]
Everolimus + LY2874455 DCME4KT LY2874455 Ewing sarcoma (Cell Line: TC-71) [5]
Everolimus + Tacrolimus DCTB9F9 Tacrolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Everolimus + Etomidate DCUIU3R Etomidate Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Exherin + Everolimus DCN8SVJ Exherin Ewing sarcoma (Cell Line: TC-71) [5]
Furazolidone + Everolimus DCS3I92 Furazolidone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
GDC-0084 + Everolimus DCYZ3LG GDC-0084 Ewing sarcoma (Cell Line: TC-71) [5]
Ibutilide + Everolimus DCMB3PT Ibutilide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Idarubicin + Everolimus DCOZ33N Idarubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Imatinib + Everolimus DCSZVMJ Imatinib Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Ispinesib + Everolimus DC771QB Ispinesib Ewing sarcoma (Cell Line: TC-71) [5]
IT-141 + Everolimus DCCBFA3 IT-141 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
IT-141 + Everolimus DCG5UV8 IT-141 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
JQ1 + Everolimus DCHT1GS JQ1 Ewing sarcoma (Cell Line: TC-71) [5]
Lacosamide + Everolimus DC1RC1K Lacosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
LEE011 + Everolimus DCR0X34 LEE011 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Lefaxin + Everolimus DCKBULV Lefaxin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Linagliptin + Everolimus DCWI4UI Linagliptin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Loperamide + Everolimus DCK40P4 Loperamide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
LY2523355 + Everolimus DC5B00B LY2523355 Ewing sarcoma (Cell Line: TC-71) [5]
Maprotiline + Everolimus DCJ13TS Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Mecamylamine + Everolimus DCPPMDU Mecamylamine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Mephenytoin + Everolimus DCGE223 Mephenytoin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Mesalazine + Everolimus DC0CCO2 Mesalazine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Methylergonovine + Everolimus DCBEEB7 Methylergonovine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Mitomycin + Everolimus DC6YO7H Mitomycin Ewing sarcoma (Cell Line: TC-71) [5]
MK-2206 + Everolimus DC2BU3S MK-2206 Ewing sarcoma (Cell Line: TC-71) [5]
Moricizine + Everolimus DC3UA5U Moricizine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Mycophenolic acid + Everolimus DC0AOBU Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Nizatidine + Everolimus DC6TT6K Nizatidine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Norcisapride + Everolimus DCRHI0L Norcisapride Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Novobiocin + Everolimus DCA1G5P Novobiocin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
NVP-AUY922 + Everolimus DCXXRE3 NVP-AUY922 Ewing sarcoma (Cell Line: TC-71) [5]
Olanzapine + Everolimus DCL6RK5 Olanzapine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Ombrabulin + Everolimus DCAYIW0 Ombrabulin Ewing sarcoma (Cell Line: TC-71) [5]
Oseltamivir + Everolimus DCSSRYN Oseltamivir Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
OSI-027 + Everolimus DCEVWJY OSI-027 Ewing sarcoma (Cell Line: TC-71) [5]
Panobinostat + Everolimus DCVV7IK Panobinostat Ewing sarcoma (Cell Line: TC-71) [5]
Pazopanib HCl + Everolimus DCIT9CE Pazopanib HCl Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Pentamidine + Everolimus DCPS2GH Pentamidine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Pinacidil + Everolimus DC01LZV Pinacidil Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Ribavirin-TP + Everolimus DCQC8LM Ribavirin-TP Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Sitagliptin + Everolimus DCYXX0J Sitagliptin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Steroid derivative 1 + Everolimus DCGA8W4 Steroid derivative 1 Ewing sarcoma (Cell Line: TC-71) [5]
Sumatriptan + Everolimus DCY1KGE Sumatriptan Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Tacrine + Everolimus DCPD7PO Tacrine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Tamoxifen + Everolimus DCIGFMD Tamoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Terameprocol + Everolimus DCMAPY8 Terameprocol Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Terazosin + Everolimus DCMBZHK Terazosin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Teriflunomide + Everolimus DCDFNLR Teriflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Teriflunomide + Everolimus DCEEEJ2 Teriflunomide Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Testolactone + Everolimus DC5UNUE Testolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Testosterone + Everolimus DCP9YY7 Testosterone Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
THAPSIGARGIN + Everolimus DCC6Z63 THAPSIGARGIN Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Tivantinib + Everolimus DCHI86A Tivantinib Ewing sarcoma (Cell Line: TC-71) [6]
Tolazoline + Everolimus DCXIEEO Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Tolvaptan + Everolimus DC0I9LV Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Tropisetron + Everolimus DC6YIAQ Tropisetron Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Venglustat + Everolimus DC92B6A Venglustat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Verteporfin + Everolimus DCGRUUR Verteporfin Ewing sarcoma (Cell Line: TC-71) [5]
Vorinostat + Everolimus DCH3UBB Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Withaferin A + Everolimus DCRYHSA Withaferin A Ewing sarcoma (Cell Line: TC-71) [5]
Ym155 + Everolimus DC1POCJ Ym155 Ewing sarcoma (Cell Line: TC-71) [5]
Zileuton + Everolimus DCOF7DC Zileuton Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 200 DrugCom(s)
93 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Buparlisib + Everolimus DCWJ6CN Buparlisib Solid Tumors [7]
Cyclophosphamide + Everolimus DC7F9O2 Cyclophosphamide Liver Transplant [8]
Dexamethasone + Everolimus DC1IKV8 Dexamethasone Acute Lymphoblastic Leukemia ALL [9]
Dexamethasone + Everolimus DCGA61A Dexamethasone Pediatric Cancer [10]
Eribulin + Everolimus DCMG5TF Eribulin Triple Negative Breast Cancer [11]
Eribulin + Everolimus DCV4BXL Eribulin Estrogen Receptor Negative [12]
Everolimus + Etoposide DC6JCXF Etoposide Recurrent Childhood Brain Tumor [13]
Everolimus + Bortezomib DC0BKSC Bortezomib 714leukemia [14]
Everolimus + VATALANIB DC0PRK5 VATALANIB Gastrinoma [15]
Everolimus + Sunitinib DC1NW6M Sunitinib Renal Cell Carcinoma [16]
Everolimus + Letrozole DC1XTHT Letrozole Postmenopausal Women [17]
Everolimus + Carboplatin DC23FCZ Carboplatin Breast Cancer [18]
Everolimus + Pazopanib DC3BTFP Pazopanib Solid Tumor [19]
Everolimus + Cyclosporin A DC43PBW Cyclosporin A Kidney Transplantation [20]
Everolimus + Exemestane DC4MTXP Exemestane Breast Cancer [21]
Everolimus + Temozolomide DC6DA4J Temozolomide Melanoma (Skin) [22]
Everolimus + Hydroxychloroquine DC8H66W Hydroxychloroquine Metastatic Clear Cell Renal Cell Carcinoma [23]
Everolimus + Pemetrexed DC8UB8F Pemetrexed Non Small Cell Lung Cancer [24]
Everolimus + Capecitabine DC96HAK Capecitabine Metastatic Gastric Cancer [25]
Everolimus + Vandetanib DC9I00B Vandetanib Advanced Malignant Neoplasm [26]
Everolimus + Tivozanib DCEFV5W Tivozanib Gastrointestinal Cancer [27]
Everolimus + Mycophenolic acid DCEGNP5 Mycophenolic acid Chronic Allograft Injury [28]
Everolimus + Temozolomide DCELLU9 Temozolomide Brain and Central Nervous System Tumors [29]
Everolimus + Sunitinib DCG6XFX Sunitinib Metastatic Renal Cell Carcinoma [30]
Everolimus + Erlotinib DCJHBPT Erlotinib Unspecified Adult Solid Tumor, Protocol Specific [31]
Everolimus + Cyclosporin A DCJVUA2 Cyclosporin A Kidney Dysfunction [32]
Everolimus + Imatinib DCL26ZV Imatinib Gastrointestinal Stromal Tumors [33]
Everolimus + Exemestane DCL5AZI Exemestane Metastatic Breast Cancer [34]
Everolimus + Anastrozole DCLQUUS Anastrozole Solid Tumors [35]
Everolimus + Topotecan DCLVR0I Topotecan Endometrial Cancer [36]
Everolimus + Bicalutamide DCOJ1TH Bicalutamide Prostate Cancer [37]
Everolimus + Midostaurin DCP8Q16 Midostaurin Acute Myeloid Leukemia [38]
Everolimus + Pasireotide DCQB2UD Pasireotide Neuroendocrine Tumors [39]
Everolimus + Vorinostat DCV85IB Vorinostat Advanced Cancer [40]
Everolimus + Pasireotide DCYC3YR Pasireotide Castrate Resistant Prostate Cancer [41]
Everolimus + AEE-788 DCZU17G AEE-788 Brain and Central Nervous System Tumors [42]
Everolimus + LY2835219 DCHRH0E LY2835219 Breast Neoplasms [43]
Everolimus + Exemestane DCHZ936 Exemestane Neoplasms [44]
Everolimus + Etoposide DCI4ZQF Etoposide Lung Cancer [45]
Everolimus + Exemestane DCKTQTO Exemestane Breast Cancer [46]
Everolimus + Alpelisib DC1800C Alpelisib Neoplasms [44]
Everolimus + MK-4827 DC5LC1P MK-4827 Breast Cancer [47]
Everolimus + Ceritinib DC8BYYT Ceritinib ALK Positive [48]
Everolimus + Arn-509 DCA4W33 Arn-509 Prostate Cancer [49]
Everolimus + Letrozole DCBYD0M Letrozole Advanced Malignant Solid Neoplasm [50]
Everolimus + Capmatinib DCDOT50 Capmatinib Pediatric Cancer [10]
Everolimus + Ibrutinib DCGNDH3 Ibrutinib Metastatic Renal Cell Carcinoma [51]
Everolimus + INCB039110 DCIKDJU INCB039110 Classical Hodgkin Lymphoma [52]
Everolimus + Enzalutamide DCL9TE9 Enzalutamide Prostate Cancer [53]
Everolimus + Fosbretabulin DCNRSEY Fosbretabulin Neuroendocrine Tumors [54]
Everolimus + Sotrastaurin acetate DCP5CT2 Sotrastaurin acetate CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma [55]
Everolimus + LEE011 DCS1DQL LEE011 Pediatric Cancer [10]
Fulvestrant + Everolimus DC5OHFG Fulvestrant Breast Cancer [56]
Fulvestrant + Everolimus DCR7VGL Fulvestrant Metastatic Breast Cancer [57]
Gefitinib + Everolimus DC0QVJU Gefitinib Lung Cancer [58]
Gefitinib + Everolimus DCJCM9J Gefitinib Brain and Central Nervous System Tumors [59]
HKI-272 + Everolimus DCTX6VM HKI-272 Advanced Malignant Solid Neoplasm [60]
Idelalisib + Everolimus DCN0GD0 Idelalisib Indolent Non-Hodgkin's Lymphoma [61]
Lenalidomide + Everolimus DCAVIXU Lenalidomide Adult Nasal Type Extranodal NK/T-cell Lymphoma [62]
Leuprolide + Everolimus DCJ7016 Leuprolide Prostate Cancer [63]
Panobinostat + Everolimus DC82Y53 Panobinostat Diffuse Large B-cell Lymphoma [64]
Panobinostat + Everolimus DC8R69P Panobinostat Lymphoma [65]
RAD-1901 + Everolimus DCW3UDM RAD-1901 Breast Cancer [66]
RTB101 + Everolimus DCQOP4C RTB101 Cancer [67]
Trametinib + Everolimus DCFMCMZ Trametinib Recurrent World Health Organization (WHO) Grade II Glioma [68]
Vemurafenib + Everolimus DCC3LRD Vemurafenib Advanced Cancer [69]
CB-839 + Everolimus DCUVHTP CB-839 Clear Cell Renal Cell Carcinoma [70]
Everolimus + Everolimus DCA7FI6 Everolimus Clear Cell Renal Carcinoma [71]
Everolimus + Goserelin DC1L2BB Goserelin Metastatic Breast Cancer [72]
Everolimus + Carboplatin DC23AQP Carboplatin Metastatic Melanoma [73]
Everolimus + Mycophenolate mofetil DC6K1NQ Mycophenolate mofetil Delayed Graft Function [74]
Everolimus + Letrozole DC8R6NG Letrozole Recurrent Endometrial Carcinoma [75]
Everolimus + Erlotinib DCEOUMC Erlotinib Diffuse Intrinsic Pontine Glioma [76]
Everolimus + Hydroxychloroquine DC22PNW Hydroxychloroquine Breast Cancer Stage IIB [77]
Everolimus + Dasatinib DC3C3QB Dasatinib Glioma [78]
Everolimus + Dasatinib DC6C0HO Dasatinib Diffuse Intrinsic Pontine Glioma [76]
Everolimus + LEE011 DCCWEJZ LEE011 Neuroendocrine Tumors [79]
Everolimus + Lenvatinib DCIHQEK Lenvatinib Renal Cell Carcinoma [80]
Everolimus + Octreotide DCNH19Z Octreotide Recurrent Meningiomas [81]
Everolimus + Tacrolimus DCWJNC3 Tacrolimus Delayed Graft Function [74]
Everolimus + Carboplatin DCXB8EB Carboplatin Breast Cancer [82]
Lapatinib + Everolimus DCXJ6ZK Lapatinib Breast Neoplasms [83]
Leuprolide + Everolimus DC4262U Leuprolide Metastatic Breast Cancer [84]
Dexamethasone + Everolimus DCQKWG1 Dexamethasone Malignant Neoplasm [85]
Everolimus + Methylprednisolone DCISY1G Methylprednisolone Transplant; Failure, Kidney [86]
Everolimus + Tacrolimus DC8BWRX Tacrolimus Liver Transplantation [87]
Everolimus + Mycophenolic acid DCE5HH1 Mycophenolic acid Chronic Kidney Disease [88]
Everolimus + Lenvatinib DCFFWWH Lenvatinib Renal Cell Carcinoma [89]
Fulvestrant + Everolimus DC4RUW5 Fulvestrant Metastatic Breast Cancer [90]
Fulvestrant + Everolimus DC94AA9 Fulvestrant Advanced or Metastatic Breast Cancer [91]
Fulvestrant + Everolimus DCHLNDL Fulvestrant Breast Cancer [92]
Everolimus + Methylprednisolone DCN0M87 Methylprednisolone Renal Transplanted Recipients [93]
Everolimus + Methylprednisolone DCX9QPS Methylprednisolone Drug Interaction Potentiation [94]
------------------------------------------------------------------------------------
⏷ Show the Full List of 93 DrugCom(s)

References

1 Everolimus FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5889).
4 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.
5 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
6 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
7 ClinicalTrials.gov (NCT01470209) A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
8 ClinicalTrials.gov (NCT03577431) Liver Transplantation With Tregs at MGH
9 ClinicalTrials.gov (NCT03740334) Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
10 ClinicalTrials.gov (NCT02813135) European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
11 ClinicalTrials.gov (NCT02616848) Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
12 ClinicalTrials.gov (NCT02120469) Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
13 ClinicalTrials.gov (NCT02015728) Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors
14 ClinicalTrials.gov (NCT00671112) Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
15 ClinicalTrials.gov (NCT00655655) Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
16 ClinicalTrials.gov (NCT00788060) A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma
17 ClinicalTrials.gov (NCT01231659) Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
18 ClinicalTrials.gov (NCT01127763) RAD001 Plus Carboplatin in Breast Cancer Patients
19 ClinicalTrials.gov (NCT01184326) Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer
20 ClinicalTrials.gov (NCT00514514) Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
21 ClinicalTrials.gov (NCT00863655) Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
22 ClinicalTrials.gov (NCT00521001) Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
23 ClinicalTrials.gov (NCT01510119) Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
24 ClinicalTrials.gov (NCT00434174) Safety of Everolimus and Pemetrexed in Lung Cancer Patients
25 ClinicalTrials.gov (NCT01099527) A Trial of RAD001/Capecitabine in Refractory Gastric Cancer
26 ClinicalTrials.gov (NCT01582191) Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer
27 ClinicalTrials.gov (NCT01058655) RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer
28 ClinicalTrials.gov (NCT01473732) Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
29 ClinicalTrials.gov (NCT00553150) Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
30 ClinicalTrials.gov (NCT01784978) Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer
31 ClinicalTrials.gov (NCT00276575) Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
32 ClinicalTrials.gov (NCT00420537) Shift to Everolimus (RAD) Kidney Sparing Study
33 ClinicalTrials.gov (NCT01275222) Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
34 ClinicalTrials.gov (NCT01626222) 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
35 ClinicalTrials.gov (NCT01197170) Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
36 ClinicalTrials.gov (NCT00703807) Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
37 ClinicalTrials.gov (NCT00630344) RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
38 ClinicalTrials.gov (NCT00819546) RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
39 ClinicalTrials.gov (NCT01469572) Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases
40 ClinicalTrials.gov (NCT01087554) Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
41 ClinicalTrials.gov (NCT01313559) Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
42 ClinicalTrials.gov (NCT00107237) AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
43 ClinicalTrials.gov (NCT02057133) A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
44 ClinicalTrials.gov (NCT02077933) Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
45 ClinicalTrials.gov (NCT00807755) Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
46 ClinicalTrials.gov (NCT02732119) Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.
47 ClinicalTrials.gov (NCT03154281) Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast
48 ClinicalTrials.gov (NCT02321501) Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
49 ClinicalTrials.gov (NCT02106507) ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate
50 ClinicalTrials.gov (NCT02152943) Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
51 ClinicalTrials.gov (NCT02599324) Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors
52 ClinicalTrials.gov (NCT03697408) Itacitinib + Everolimus in Hodgkin Lymphoma
53 ClinicalTrials.gov (NCT02125084) Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer
54 ClinicalTrials.gov (NCT03014297) Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
55 ClinicalTrials.gov (NCT01854606) Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma
56 ClinicalTrials.gov (NCT00570921) Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
57 ClinicalTrials.gov (NCT01797120) Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
58 ClinicalTrials.gov (NCT00096486) Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
59 ClinicalTrials.gov (NCT00085566) Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
60 ClinicalTrials.gov (NCT03065387) Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation
61 ClinicalTrials.gov (NCT01088048) Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
62 ClinicalTrials.gov (NCT01075321) Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
63 ClinicalTrials.gov (NCT00943956) Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer
64 ClinicalTrials.gov (NCT00978432) Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
65 ClinicalTrials.gov (NCT00967044) Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma
66 ClinicalTrials.gov (NCT05563220) Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer
67 ClinicalTrials.gov (NCT01508104) Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
68 ClinicalTrials.gov (NCT04485559) Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
69 ClinicalTrials.gov (NCT01596140) Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer
70 ClinicalTrials.gov (NCT03163667) CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
71 ClinicalTrials.gov (NCT01408004) Rotating Pazopanib and Everolimus to Avoid Resistance
72 ClinicalTrials.gov (NCT02313051) Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
73 ClinicalTrials.gov (NCT01014351) Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
74 ClinicalTrials.gov (NCT01878786) A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
75 ClinicalTrials.gov (NCT03008408) A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
76 ClinicalTrials.gov (NCT02233049) Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
77 ClinicalTrials.gov (NCT03032406) CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
78 ClinicalTrials.gov (NCT03352427) Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
79 ClinicalTrials.gov (NCT03070301) A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
80 ClinicalTrials.gov (NCT03173560) Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
81 ClinicalTrials.gov (NCT02333565) Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas
82 ClinicalTrials.gov (NCT02531932) Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
83 ClinicalTrials.gov (NCT01499160) Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
84 ClinicalTrials.gov (NCT02344550) Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
85 ClinicalTrials.gov (NCT03839940) Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
86 ClinicalTrials.gov (NCT01680861) Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
87 ClinicalTrials.gov (NCT02115113) REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy
88 ClinicalTrials.gov (NCT02334488) Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
89 ClinicalTrials.gov (NCT02811861) Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
90 ClinicalTrials.gov (NCT02404051) Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
91 ClinicalTrials.gov (NCT06105632) A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
92 ClinicalTrials.gov (NCT02137837) S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
93 ClinicalTrials.gov (NCT00371826) SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus
94 ClinicalTrials.gov (NCT02077556) Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients